Revision history of "Long run outcomes using singleagent belantamab mafodotin inside sufferers using relapsed or perhaps refractory multiple myeloma 13month followup from your critical DREAMM2 research"
From EECH Central
Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.